Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Rangering i aksjer #10859
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Aksjekurs
$25.15
Markedsverdi
$253.18M
Endring (1 dag)
0.00%
Endring (1 år)
-12.08%
Land
FR
Handel Eurobio Scientific Société anonyme (ALERS)

Kategori

P/S-forhold for Eurobio Scientific Société anonyme (ALERS)
P/S-forhold per July 2026 TTM: 1.28
Ifølge Eurobio Scientific Société anonyme sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 1.28. Ved slutten av 2023 hadde selskapet et P/S-forhold på 1.40.
P/S-historikk for Eurobio Scientific Société anonyme fra 2007 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 1.28 -23.52%
2024 1.67 19.00%
2023 1.40 2.89%
2022 1.36 -13.72%
2021 1.58 57.17%
2020 1.01 16.94%
2019 0.86 46.29%
2018 0.59 -39.62%
2017 0.97 11.92%
2016 0.87 -23.97%
2015 1.14 -2.85%
2014 1.18 -2.10%
2013 1.20 -79.96%
2012 6.00 -18.06%
2011 7.33 -9.92%
2010 8.14 -61.46%
2009 21.11 20.48%
2008 17.52 -18.37%
2007 21.46 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
3.50 174.00%
US
4.78 273.92%
US
2.75 115.61%
IE
3.08 140.94%
US
8.26 546.98%
US